BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 1497347)

  • 21. Functional changes in the conformation of thrombospondin-1 during complexation with fibronectin or heparin.
    Dardik R; Lahav J
    Exp Cell Res; 1999 May; 248(2):407-14. PubMed ID: 10222132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombospondin binds to Staphylococcus aureus and promotes staphylococcal adherence to surfaces.
    Herrmann M; Suchard SJ; Boxer LA; Waldvogel FA; Lew PD
    Infect Immun; 1991 Jan; 59(1):279-88. PubMed ID: 1987042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isolation and characterization of a heparin-binding domain from the amino terminus of platelet thrombospondin.
    Dixit VM; Grant GA; Santoro SA; Frazier WA
    J Biol Chem; 1984 Aug; 259(16):10100-5. PubMed ID: 6236212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of heparin with fibronectin and isolated fibronectin domains.
    Ingham KC; Brew SA; Atha DH
    Biochem J; 1990 Dec; 272(3):605-11. PubMed ID: 2268289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interactions between thrombospondin and the small proteoglycan decorin: interference with cell attachment.
    Winnemöller M; Schön P; Vischer P; Kresse H
    Eur J Cell Biol; 1992 Oct; 59(1):47-55. PubMed ID: 1468447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding of fibronectin to alpha-granule-deficient platelets.
    Ginsberg MH; Wencel JD; White JG; Plow EF
    J Cell Biol; 1983 Aug; 97(2):571-3. PubMed ID: 6309863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence that binding to the carboxyl-terminal heparin-binding domain (Hep II) dominates the interaction between plasma fibronectin and heparin.
    Benecky MJ; Kolvenbach CG; Amrani DL; Mosesson MW
    Biochemistry; 1988 Sep; 27(19):7565-71. PubMed ID: 3207688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of two murine monoclonal antibodies (P10, P12) directed against different determinants on human blood platelet thrombospondin.
    Clezardin P; McGregor JL; Lyon M; Clemetson KJ; Huppert J
    Eur J Biochem; 1986 Jan; 154(1):95-102. PubMed ID: 2417838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective inhibition of platelet macroaggregate formation by a recombinant heparin-binding domain of human thrombospondin.
    Legrand C; Morandi V; Mendelovitz S; Shaked H; Hartman JR; Panet A
    Arterioscler Thromb; 1994 Nov; 14(11):1784-91. PubMed ID: 7947604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Location and partial characterization of the heparin-binding fragment of platelet thrombospondin.
    Raugi GJ; Mumby SM; Ready CA; Bornstein P
    Thromb Res; 1984 Oct; 36(2):165-75. PubMed ID: 6568771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombospondin-platelet interactions. Role of divalent cations, wall shear rate, and platelet membrane glycoproteins.
    Agbanyo FR; Sixma JJ; de Groot PG; Languino LR; Plow EF
    J Clin Invest; 1993 Jul; 92(1):288-96. PubMed ID: 7686921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a novel binding site to the integrin alphaIIbbeta3 located in the C-terminal heparin-binding domain of human plasma fibronectin.
    Mohri H; Tanabe J; Katoh K; Okubo T
    J Biol Chem; 1996 Jun; 271(26):15724-8. PubMed ID: 8663002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteolytic studies on the structure of bovine von Willebrand factor.
    Mascelli MA; Kirby EP
    Biochemistry; 1988 Feb; 27(4):1274-84. PubMed ID: 2452652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of an anti-thrombospondin monoclonal antibody (P8) that inhibits human blood platelet functions. Normal binding of P8 to thrombin-activated Glanzmann thrombasthenic platelets.
    Boukerche H; McGregor JL
    Eur J Biochem; 1988 Jan; 171(1-2):383-92. PubMed ID: 3338471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular mechanisms of avian neural crest cell migration on fibronectin and laminin.
    Perris R; Paulsson M; Bronner-Fraser M
    Dev Biol; 1989 Nov; 136(1):222-38. PubMed ID: 2509262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complex formation of human thrombospondin with osteonectin.
    Clezardin P; Malaval L; Ehrensperger AS; Delmas PD; Dechavanne M; McGregor JL
    Eur J Biochem; 1988 Aug; 175(2):275-84. PubMed ID: 3402455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary structure of human plasma fibronectin. Characterization of a 31,000-dalton fragment from the COOH-terminal region containing a free sulfhydryl group and a fibrin-binding site.
    Garcia-Pardo A; Pearlstein E; Frangione B
    J Biol Chem; 1985 Aug; 260(18):10320-5. PubMed ID: 4019516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell surface proteoglycan binds mouse mammary epithelial cells to fibronectin and behaves as a receptor for interstitial matrix.
    Saunders S; Bernfield M
    J Cell Biol; 1988 Feb; 106(2):423-30. PubMed ID: 2963012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary structure of a DNA- and heparin-binding domain (Domain III) in human plasma fibronectin.
    Calaycay J; Pande H; Lee T; Borsi L; Siri A; Shively JE; Zardi L
    J Biol Chem; 1985 Oct; 260(22):12136-41. PubMed ID: 3900070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibronectin gelatin-binding activity: effects of platelet thrombospondin, serum, and plasma.
    Gelder FB; Brown ST
    J Lab Clin Med; 1987 Nov; 110(5):548-57. PubMed ID: 3312442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.